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Summary
 
Surface receptors involved in natural killer (NK) cell triggering during the process of tumor cell
lysis have recently been identified. Of these receptors, NKp44 is selectively expressed by IL-2–
activated NK cells and may contribute to the increased efficiency of activated NK cells to me-
diate tumor cell lysis. Here we describe the molecular cloning of NKp44. Analysis of the
cloned cDNA indicated that NKp44 is a novel transmembrane glycoprotein belonging to the
Immunoglobulin superfamily characterized by a single extracellular V-type domain. The
charged amino acid lysine in the transmembrane region may be involved in the association of
NKp44 with the signal transducing molecule killer activating receptor–associated polypeptide
(KARAP)/DAP12. These molecules were found to be crucial for the surface expression of
NKp44. In agreement with data of NKp44 surface expression, the NKp44 transcripts were
strictly confined to activated NK cells and to a minor subset of TCR-
 
g
 
/
 
d
 
1
 
 T lymphocytes.
Unlike genes coding for other receptors involved in NK cell triggering or inhibition, the
NKp44 gene is on human chromosome 6.
Key words: natural killer cells • activating receptor • natural cytotoxicity • immunoglobulin 
superfamily • cDNA
 
T
 
he mechanism by which NK cells lyse certain virally
infected or tumor cells while sparing normal cells has
recently been elucidated. They express MHC class I–specific
inhibitory receptors (killer inhibitory receptors [KIRs])
 
1
 
that block NK cell function when interacting with their
ligand(s) (1). Thus, the expression of inadequate amounts
of MHC molecules at the cell surface renders cells suscepti-
ble to NK cell lysis. On the other hand, the molecular
mechanism(s) responsible for NK cell triggering remains
largely unknown. Although the activating counterparts
of KIRs have been identified (killer activating receptors
[KAR]), their contribution to NK cell triggering is clearly
limited to the case of MHC class I
 
1
 
 target cells. However,
a major function of NK cells is to kill cells that do not ex-
press MHC class I molecules, thus implying a major role in
NK cell triggering of receptors recognizing non-MHC
ligands. In this context, we have recently described two
novel, highly NK-specific, receptor molecules (termed
NKp46 and NKp44) that are involved in NK cell trigger-
ing during the process of natural cytotoxicity. Whereas
NKp46 is expressed by all resting and activated NK cells
(2), NKp44 is selectively expressed by NK cells only upon
culture in IL-2 (3). In this respect, the de novo expression
of NKp44 may play a relevant role in the marked increase
of cytolytic activity displayed by the so-called LAK cells (4)
that have been used in the adoptive immunotherapy of
cancer (5, 6). Molecular cloning of NKp46 (7) has recently
revealed a novel member of the Ig superfamily (Ig-SF) as-
sociated to CD3
 
z
 
, a signal transducing molecule containing
immunoreceptor tyrosine-based activation motifs (ITAM).
In this study, we report the molecular cloning of NKp44.
NKp44 also represents a novel member of the Ig-SF which
differs from NKp46 in that it is associated with the recently
identified signal transducing molecule killer activating
receptor–associated polypeptide (KARAP)/DAP12 (3).
Moreover, the gene encoding NKp44 is located on human
 
1
 
Abbreviations used in this paper:
 
 ITAM, immunoreceptor tyrosine-based
activating motif; ITIM, immunoreceptor tyrosine-based inhibitory motif;
KARAP, killer activating receptor–associated polypeptide; KIR, killer in-
hibitory receptor; ORF, open reading frame; RT-PCR, reverse tran-
scriptase-polymerase chain reaction; SF, superfamily. 
788
 
Molecular Cloning of the NKp44 Receptor
 
chromosome 6 whereas NKp46 and most of the NK re-
ceptors belonging to the Ig-SF are encoded by genes on
chromosome 19 (1, 7).
 
Materials and Methods
 
cDNA Library Construction.
 
The expression cDNA library
was prepared in VR1012 plasmid (Vical Inc.) using RNA ex-
tracted from IL-2–activated polyclonal NK cells as described (7,
8), and was divided into 10 fractions of 
 
z
 
10
 
5
 
 clones each.
 
Library Screening by cDNA Expression in COS-7 Cells.
 
The li-
brary screening procedure was performed as described (7, 9).
Briefly, cDNA library was transiently transfected in COS-7 cells;
selection of positive pools was performed by immunocytochemi-
cal staining using the specific anti-NKp44 mAb Z231 (3) and sib
selection.
 
DNA Sequencing.
 
DNA sequencing was performed using
d-Rhodamine Terminator Cycle Sequencing Kit and a 377 Ap-
plied Biosystems Automatic Sequencer (Perkin Elmer-Applied
Biosystems).
 
Reverse Transcriptase PCR (RT-PCR) Amplification of cDNAs
Encoding for NKp44 and DAP12.
 
Total RNA extracted using
RNAzol (Cinna/Biotecx) from polyclonal NK and T cell popu-
lations and clones and from different hemopoietic cell lines (Ta-
ble I) was reverse transcribed using oligo dT priming. Primers
used for cDNA amplification of complete NKp44 open reading
frame (ORF) (857 bp) were the following: 5
 
9
 
 CCA CGA GCG
CAC AGG AAA AGG (NKp44 ORF UP) and 5
 
9
 
 TCA CAA
AGT GTG TTC ATC ATC ATC ATC GCT TAT CTT AGT
CC (NKp44 ORF DOWN). Amplification was performed for
30 cycles (30 s at 94
 
8
 
C, 30 s at 65
 
8
 
C, and 30 s at 72
 
8
 
C), followed
by a 7-min incubation at 72
 
8
 
C, utilizing TAQ-GOLD (Perkin
Elmer-Applied Biosystems) after preactivation for 15 min at
95
 
8
 
C. The cDNA obtained from a polyclonal NK cell population
(NKp44 ORF) was subcloned in pcDNA3.1/V5/His
 
2
 
TOPO
vector (Invitrogen) and sequenced. Primers used for cDNA am-
plification of complete DAP12 ORF (10) (353 bp) were the fol-
lowing: 5
 
9
 
 TCA TGG GGG GAC TTG AAC C (DAP12 UP)
and 5
 
9
 
 GAT TCG GGC TCA TTT GTA ATA C (DAP12
DOWN). Amplification was performed for 30 cycles (30 s at
94
 
8
 
C, 30 s at 60
 
8
 
C, and 30 s at 72
 
8
 
C), followed by a 7-min incu-
bation at 72
 
8
 
C. The amplification product obtained from the NK
cell clone K17 was subcloned in pCR3.1 vector (Invitrogen) and
sequenced. Polyclonal or clonal NK cell populations and clones
were obtained as previously described (2, 3, 11).
RT-PCR analysis of NKp44 and DAP12 mRNA on a panel
of different cell populations of lymphoid origin and hemopoietic
human cell lines was performed utilizing a semiquantitative PCR
technique (12, 13).
 
Transient Transfections.
 
COS-7 cells (5 
 
3
 
 10
 
5
 
 per plate) were
cotransfected with VR1012-15C and pCR3.1-DAP12 or with
pcDNA3.1/V5/His
 
2
 
TOPO NKp44 ORF (pcDNA3.1–NKp44
ORF) and pCR3.1–DAP12 constructs by the DEAE-dextran
method as described (11). Cells were stained with different anti-
NKp44 mAbs (Z231, IgG1; AZ140, IgG1; KS38, IgM) followed
by a phycoerythrin-conjugated goat antibody to mouse IgG1 or
IgM and analyzed by flow cytometry using a FACSort
 
®
 
 (Becton
Dickinson).
 
Expression of NKp44 and DAP12 mRNA in Transfected COS-7
Cells by RT-PCR and by Dot Blot Analysis.
 
Total RNA was ex-
tracted from COS-7 cells (untransfected, transfected with
pcDNA3.1–NKp44 ORF, or co-transfected with pcDNA3.1–
 
NKp44 ORF and pCR3.1–DAP12) utilizing CsCl gradient. Poly
A
 
1
 
 fraction was purified from total RNA using oligo dT Dyna-
beads (Dynal, Norway) following the manufacturer’s instructions.
cDNA was obtained by RT reaction using oligo dT priming start-
ing from 200 ng poly A
 
1
 
. PCR amplification of NKp44 ORF and
DAP12 ORF was carried out with the primers described above for
25 cycles, each consisting of 30 s at 95
 
8
 
C, 30 s at 60
 
8
 
C, and 30 s at
72
 
8
 
C. A 228-bp 
 
b
 
-actin fragment was amplified as control using
the following primers: 5
 
9
 
 ACT CCA TCA TGA AGT GTG ACG
(
 
b
 
-actin UP) and 5
 
9
 
 CAT ACT CCT GCT TGC TGA TCC
(
 
b
 
-actin DOWN). PCR amplification was carried out for 25 cycles,
each consisting of 30 s at 95
 
8
 
C, 30 s at 58
 
8
 
C, and 30 s at 72
 
8
 
C. As a
negative control we included for each set of primers poly A
 
1
 
 with-
out RT reaction step. PCR products were run on a 1.5% agarose
gel and stained with ethidium bromide.
For the dot blot analysis, 200 ng poly A
 
1
 
 were denatured in
60 
 
m
 
l 20
 
3
 
 SSC and 40 
 
m
 
l 37% formaldehyde at 60
 
8
 
C for 15 min
and spotted onto a positively charged nylon membrane (Gene-
Screen plus; Dupont-NEN) in 15
 
3
 
 SSC using a microfiltration
apparatus (Bio-dot; BioRad). The dot blot was hybridized with
the following probes: 857-bp NKp44 ORF fragment, 353-bp
DAP12 fragment, and 228-bp 
 
b
 
-actin fragment. cDNA probes
were 
 
32
 
P labeled by random priming (14). Blot was washed at
high stringency conditions as described (8).
 
Biochemical Characterization of the NKp44 Molecule.
 
Cyanogen
bromide Sepharose (Pharmacia, Sweden) –coupled Z231 mAb
was used to immunoprecipitate NKp44 molecules from 1%
NP-40 lysates of 
 
125
 
I surface labeled cells (DuPont-NEN) as pre-
viously described (2, 3). Immunoprecipitates were analyzed by
discontinuous SDS-PAGE under reducing conditions (5% 2-mer-
captoethanol).
 
Biochemical Characterization of the NKp44-associated KARAP/
DAP12 Molecules.
 
NK cells were treated with sodium pervana-
date (3) or with KS38 (IgM, anti-NKp44) mAb (3 
 
3
 
 10
 
6
 
, 5 
 
m
 
g, 30
min, 4
 
8
 
C) followed by affinity purified F(ab
 
9
 
)
 
2
 
 rabbit anti–mouse
IgM (1.5 
 
m
 
g, 1 min, 37
 
8
 
C, ZYMED). Untreated and treated cells
were lysed in 1% digitonin and immunoprecipitated with various
mAbs as previously described (3). Samples were analyzed in SDS-
PAGE, transferred to Immobilon P (Millipore Corp.) and the
membranes probed with PY20-HRPO (anti-phosphotyrosine
mAb; Transduction Laboratories) or with anti-Fc
 
e
 
RI
 
g
 
 rabbit anti-
serum (provided by E. Vivier, INSERM, Marseille, France) or anti-
DAP12 rabbit antiserum (SI-28) followed by donkey anti–rabbit
HRPO (Amersham, UK). The Renaissance Chemiluminescence
Kit (Dupont-NEN) was used for detection. SI-28 antiserum was
obtained as previously described (11), using the COOH-terminal
peptide (SDVYSDLNTQRPYYK) of DAP12 molecule (10).
 
Analysis of NKp44 Transcript Expression by Northern Blotting.
 
5
 
m
 
g of total RNA prepared from LCL721.221 and Jurkat cell
lines, NK cell clones and polyclonal NK cell populations using
CsCl gradient was size-fractionated by denaturing agarose gel
electrophoresis and transferred onto a positively charged nylon
membrane (GeneScreen plus; DuPont-NEN). Northern blot was
performed under high stringency conditions as described (8). The
NKp44 cDNA probe (857-bp fragment NKp44 ORF) and the
228-bp 
 
b
 
-actin probe were 
 
32
 
P labeled by random priming (14).
 
Southern Blotting and Chromosomal Localization of NKp44 Gene.
 
10 
 
m
 
g of genomic DNA extracted from human, monkey, and
mouse was digested with EcoRI, HindIII, or SacI restriction en-
zymes. DNA was size-fractionated by electrophoresis on a 0.8%
agarose gel, transferred onto a positively charged nylon mem-
brane (DuPont-NEN), hybridized as described (8, 14), and
washed at low stringency conditions (0.5
 
3
 
 SSC at 65
 
8
 
C). 
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The Somatic Cell Hybrid blot (BIOS Laboratories) was used
to assign NKp44 gene to a specific chromosome by Southern
blotting. The NKp44 ORF probe was used for high stringency
hybridization; washes were performed as previously described (8).
Chromosomal assignment was further confirmed by PCR on
DNA from human–hamster monochromosomal hybrids (BIOS
Laboratories) utilizing the following primers: 5
 
9
 
 CCA CGA
GCG CAC AGG AAA AGG (NKp44 ORF UP) and 5
 
9
 
 GTA
GAT TCT ACA CCA GTA ATG (15C-REV2). These primers
allowed us to discriminate, by the size of the amplified products,
between genomic and cDNA amplified sequences.
 
Results
 
Molecular Cloning of the cDNA Encoding the NKp44 Re-
ceptor.
 
The availability of different mAbs specific for NKp44
molecules allowed us to attempt the isolation of the cDNA
Figure 1. NKp44 surface ex-
pression in COS-7 cell transfec-
tants. (A) Cell surface expression
of NKp44 protein in COS-7
cells requires cotransfection with
DAP12 cDNA. COS-7 cells
were cotransfected with NKp44
ORF and DAP12 cDNAs (up-
per panels) and stained with
three different anti-NKp44
mAbs: Z231, AZ140, and KS38.
Lower panels represent COS-7
cells transfected with DAP12 or
NKp44 ORF cDNAs alone and
stained with the prototype Z231
mAb. Cells were then stained
with phycoerythrin–conjugated
goat anti–mouse IgG1 or IgM
and analyzed by flow cytometry.
White profiles represent cells in-
cubated with the second reagent
only. Although not shown, the
anti-NKp44 mAbs AZ140 and
KS38 failed to stain COS-7 cells
transfected with NKp44 ORF or
DAP12 cDNAs alone. In each
panel, the percent of positive
cells is indicated; numbers in pa-
rentheses indicate the mean fluo-
rescence intensity. (B) Expres-
sion of NKp44 and DAP12
mRNA in COS-7 cell transfec-
tants. NKp44 and DAP12
mRNA expression was analyzed
by RT-PCR and dot blot using
poly A1 RNA (see Materials and
Methods). On the left, RT-
PCR was performed using prim-
ers specific for NKp44, DAP12,
and b-actin. (Lane 1) Untrans-
fected COS-7 cells; (lane 2)
NKp44 transfected COS-7 cells;
(lane 3) NKp44/DAP12 cotrans-
fected COS-7 cells; (lane 4) non-
retrotranscribed poly A1 RNA;
(lane 5) NK cell clone LOS64;
(lane 6) negative control (PCR
reaction mix without cDNA);
(lane 7) HinfI digested fX 174
molecular weight markers. On
the right, a dot blot prepared us-
ing poly A1 RNA was hybrid-
ized with NKp44, DAP12, and
b-actin probes. (lane a) NK cell
clone C-11; (lane b) untrans-
fected COS-7 cells; (lane c) mock transfected COS-7 cells; (lane d) NKp44 transfected COS-7 cells; (lane e) NKp44/DAP12 cotransfected COS-7 cells.
(C) Biochemical analysis of NKp44 glycoproteins. A polyclonal NK cell population (lanes a and b), and COS-7 cells, untransfected (lane c) or cotrans-
fected with NKp44 and DAP12 cDNAs (lanes d and e), were surface labeled with 125I and immunoprecipitated with BAB281 (anti-NKp46) (lanes a and
d) or Z231 (anti-NKp44) (lanes b, c, and e) mAbs. Samples were analyzed in a 11% SDS-PAGE under reducing conditions. Molecular mass markers (kD)
are indicated on the right. 
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encoding NKp44 by an expression cloning strategy. To this
end, a cDNA library was prepared from human NK cells
and divided into 10 fractions of 
 
z
 
10
 
5
 
 independent recom-
binant clones. Individual fractions were transiently trans-
fected in COS-7 cells and analyzed by immunocytochemi-
cal staining using the prototype NKp44-specific mAb Z231
(3). The first screening yielded 2 (out of 10) positive frac-
tions. By subsequent screening of progressively smaller
cDNA library pools, we obtained positive fractions, each
containing 
 
z
 
3 
 
3
 
 10
 
3
 
 recombinants. Further attempts aimed
at obtaining positive pools of smaller size (e.g., 500 recom-
binants/pool) were unsuccessful. However, cotransfection
of pairs of these small pools allowed us to identify two
pools (termed C67 and C68) yielding Z231
 
1
 
 COS-7 cells.
Since individual transfection of C67 and C68 pools gave
negative results, a possible explanation was that NKp44 ex-
pression at the surface of COS-7 cells required cotransfec-
tion with other molecule(s). On the basis of this assump-
tion, the C67 fraction was transfected with progressively
smaller pools of C68. A single clone (clone 15C) was iso-
lated that could direct surface expression of the NKp44
protein when cotransfected with the C67 fraction. Since
we recently demonstrated that NKp44 is associated with
KARAP/DAP12 ITAM-bearing molecules (3), we ana-
lyzed whether these molecules were required for NKp44
expression at the cell surface. Indeed, cotransfection of
clone 15C and DAP12 cDNAs resulted in surface expres-
sion of NKp44 (not shown). This clearly indicated that
clone 15C encoded the NKp44 molecule. Importantly, in
agreement with these results, DAP12 cDNA could be am-
plified by PCR from the C67 library fraction, thus con-
firming that, at least in COS-7 cells, DAP12 is required for
the surface expression of NKp44.
Next, COS-7 cells were either cotransfected with NKp44
ORF and DAP12 cDNAs or transfected separately with
the individual constructs and stained with different anti-
NKp44 mAbs (including Z231, AZ140, and KS38). Fig.
1 A shows that COS-7 cells were efficiently stained by the
anti-NKp44 mAbs only when cotransfected with both
NKp44 ORF and DAP12 cDNAs. On the contrary, COS-7
cells transfected with NKp44 ORF cDNA alone either
failed to express NKp44 or (in some experiments) displayed
a low level of NKp44 surface expression. As illustrated in
Fig. 1 B, the expression of NKp44 and DAP12 mRNA in
COS-7 cell transfectants was checked both by RT-PCR
and by dot blot analysis. Surface molecules reacting with
anti-NKp44 mAb were immunoprecipitated from 
 
125
 
I sur-
face labeled COS-7 cells transfected with NKp44 ORF and
DAP12 cDNAs. As shown in Fig. 1 C, the surface mole-
cules immunoprecipitated from COS-7 cell transfectants
(lane e) displayed a molecular size similar to that of mole-
cules isolated from activated NK cells (lane b).
Notably, cotransfection of COS-7 cells with NKp44
ORF and cDNAs encoding for other ITAM-bearing mol-
ecules, such as CD3
 
z
 
 or Fc
 
e
 
RI
 
g
 
 (15), did not result in
NKp44 surface expression (not shown). Thus, we can
conclude that neither CD3
 
z
 
 nor Fc
 
e
 
RIg can substitute
KARAP/DAP12 to allow surface expression of NKp44. In
this context, we previously showed that, in activated NK
cells, NKp44 molecules do not associate with CD3z mole-
cules (3). In Fig. 2 A, we show that NKp44 do not associ-
ate with FceRIg chains either. On the other hand, FceRIg
associated with NKp46. Remarkably, the use of an antise-
rum specific for the recently cloned DAP12 molecules for-
mally demonstrates that DAP12 is identical to the previ-
ously described NKp44-associated KARAP molecules (3,
16). As shown in Fig. 2 B, in NKp44 immunoprecipitates
derived from activated NK cells treated with sodium per-
vanadate, the DAP12-specific antiserum recognized both
nonphosphorylated and tyrosine-phosphorylated KARAP
molecules. Moreover, as shown in Fig. 2 C, tyrosine phos-
phorylation of the NKp44-associated KARAP/DAP12
molecules also occurred when cross-linking of NKp44
molecules was induced by a specific mAb. Taken together,
these data may suggest a direct involvement of KARAP/
DAP12 molecules in the signal transduction leading to the
NKp44-dependent NK cell activation.
Nucleotide sequence analysis showed that the 1,192-bp
isolated cDNA (clone 15C) contained a 828-bp ORF pre-
ceded by a 338-bp 59 untranslated region. The ORF en-
coded a 276–amino acid (aa) type I transmembrane protein
belonging to the Ig-SF. This protein is characterized by a
Figure 2. Association of NKp44
with KARAP/DAP12 ITAM-bear-
ing molecules. (A) 1% digitonin cell
lysates derived from a polyclonal NK
cell population were immunopre-
cipitated with either BAB281 (anti-
NKp46) or Z231 (anti-NKp44)
mAbs. Samples were analyzed in a 15% SDS-PAGE under reducing con-
ditions, transferred to PVDF membranes, and probed with the anti-
FceRIg antiserum. (B) 1% digitonin cell lysates derived from a polyclonal
NK cell population, untreated or treated with sodium pervanadate, were
immunoprecipitated with mAbs to the indicated molecules. Samples were
analyzed in a 15% SDS-PAGE under reducing conditions, transferred to
PVDF membranes, and probed with either the antiphosphotyrosine mAb
(anti-PTyr) or the anti-DAP12 antiserum. (C) A polyclonal NK cell popu-
lation was treated or not treated with KS38 (anti-NKp44) mAb or sodium
pervanadate. Cell lysates were immunoprecipitated with Z231 (anti-
NKp44) mAb. Samples were analyzed in a 15% SDS-PAGE under reduc-
ing conditions, transferred to PVDF membranes, and probed with the
antiphosphotyrosine mAb (anti-PTyr). Ig(L), Ig light chains; P-z, Tyr-
phosphorylated CD3z; P-DAP12, Tyr-phosphorylated KARAP/DAP12,
and DAP12, unphosphorylated form of KARAP/DAP12 are indicated by
arrows. Molecular mass markers (kD) are indicated on the right.791 Cantoni et al.
21-aa leader sequence, a 169-aa extracellular region, a
23-aa transmembrane portion, and a 63-aa cytoplasmic tail
(Fig. 3). Two cysteines in the extracellular region (positions
19 and 88 of the mature protein) determine the formation
of a single Ig-related domain of the V type. Thus, the
NKp44 V domain displays the typical long spacing (68 aa)
between the two conserved cysteines as well as an arginine
at position 59 and an aspartic acid at position 82 character-
istic of Ig V domains (17). It also displays an additional pair
of cysteines at positions 34 and 42, possibly involved in the
formation of a second disulphide bond similar to that de-
scribed in the NH2-terminal V domain of the poly Ig
receptor (18). The membrane-proximal region of the
NKp44 receptor contains a high proportion of proline
(20%), serine (16%), and threonine (13%). By analogy with
other Ig-SF members, this region is predicted to display an
extended open conformation typical of hinge-like se-
quences (19). Computer search (20) revealed seven serine
and six threonine residues in the hinge-like region as puta-
tive O-glycosylation sites and an asparagine at position 159
as a potential N-linked glycosylation site. The predicted
molecular mass of the NKp44 polypeptide is z29 kD.
Thus, glycosylation of the molecule may account for the
apparent molecular mass (44 kD) of the glycoprotein iso-
lated from normal NK cells (3). The transmembrane por-
tion contains the positively charged amino acid lysine. This
may be involved in the association with the negatively
charged residue aspartic acid contained in the transmem-
brane region of KARAP/DAP12 protein (10). The cyto-
plasmic tail of NKp44 contains the amino acid sequence
ILYHTV, which fits the consensus sequence for immu-
noreceptor tyrosine-based inhibitory motif (ITIM) (i.e.,
I/LxYxxL/V) (21). Remarkably, this motif is typical of all
the HLA class I–specific inhibitory receptors, while none of
the activating NK receptors identified so far (including
CD16, p50, and NKp46) display ITIM in their cytoplasmic
region (1, 21). On the other hand, it should be stressed that
other surface receptors that are involved in cell activation,
such as the erythropoietin receptor, the stem cell factor re-
ceptor, and the IL-3 receptor b chain, are characterized by
a cytoplasmic tail containing ITIM sequences (22–24). The
homology of NKp44 with known proteins was confined to
the Ig-like V domain and limited to few members of the Ig
superfamily. In particular, a low degree of homology was
observed between the Ig-like V domain of NKp44 and that
of the human poly-Ig receptor (18) (25% identity) and of
the human CMRF35 protein (25) (29% identity).
Cellular Distribution of NKp44 Transcripts. Northern blot
analysis was performed on RNA isolated from clonal and
polyclonal NK cells as well as from LCL721.221 and Jurkat
cell lines. As shown in Fig. 4, hybridization with the
NKp44 ORF probe yielded two transcripts of z3.7 and
1.2 kb. Since the cloned 1.2-kb cDNA encodes for a 44-
kD protein that is specifically recognized and immunopre-
cipitated by anti-NKp44 mAbs, it is likely that the long
3.7-kb transcript may use a different polyadenylation site
located 39 with respect to the 1.2-kb transcript. Moreover,
analysis of the cDNA sequence 59 to the ATG initiation
codon showed that there are four in-frame stop codons,
making it unlikely that the 3.7-kb transcript may encode
for a longer protein (not shown). Whereas b-actin hybrid-
ization showed that similar amounts of RNA were loaded
in each lane, the amount of NKp44 mRNA varied consid-
erably among different NK cell clones or populations ana-
Figure 3. Predicted amino acid sequence and hydrophobicity plot of
the NKp44 receptor. (A) Amino acids included in the signal peptide are
indicated in small letters. The disulphide bond of the Ig-like V domain is
indicated. The potential O-glycosylation sites are marked by single aster-
isks, and the potential N-glycosylation site by double asterisks. The pre-
dicted transmembrane portion is underlined and the charged residue is
marked by an arrow. The ITIM sequence is boxed. These sequence data
are available from EMBL/GenBank/DDBJ under accession number
AJ225109. (B) Kyte-Doolittle hydrophobicity plot of the NKp44 protein.
Figure 4. NKp44 transcript expression in polyclonal and clonal NK
cells. Total RNA (5 mg/lane) isolated from the B-EBV cell line
LCL721.221, the leukemic T cell line Jurkat, cultured polyclonal NK cell
populations (CD, EC, and AM), two NK cell clones (82G16, 82G23),
and a CD32 NK cell expansion (LDGLRP) were hybridized with the
NKp44 ORF probe. The positions of 28S and 18S ribosomal subunits are
indicated. Arrows indicate the two NKp44-specific transcripts. The two
bottom insets represent the control hybridization with a b-actin cDNA
probe.792 Molecular Cloning of the NKp44 Receptor
lyzed. This is consistent with previous data indicating that
the amount of NKp44 expressed at the cell surface differs
among NK cell clones (3).
Further analysis of the expression of NKp44 and DAP12
mRNA in different cell populations of lymphoid origin
and in hemopoietic human cell lines was performed by a
semiquantitative RT-PCR technique. Table I shows that
all IL-2–cultured NK cell populations and clones analyzed
(all reactive with anti-NKp44 mAbs) expressed both
NKp44 and DAP12 transcripts. On the contrary, fresh PBL
expressed DAP12 but not NKp44 transcript, in agreement
with the lack of surface reactivity with anti-NKp44 mAb.
This is consistent with previous data indicating that only
activated NK cells express surface NKp44 (3). Likewise, all
Table I. NKp44 Surface Expression and RT-PCR Analysis of NKp44 and DAP12 mRNA Expression in Different Lymphocyte Cell 
Populations and Clones or in Human Cell Lines of Hemopoietic Origin
Cells NKp44 surface reactivity NKp44 transcript DAP-12 transcript
CD32 LM (polyclonal NK cells) 11 1
CD32 CD (polyclonal NK cells) 11 1
CD32 EC (polyclonal NK cells) 11 1
LDGL RP (NK expansions) 11 1
LDGL DF (NK expansions) 11 1
SA92 (NK clone) 11 1
KK52 (NK clone) 11 1
LOR402 (NK clone) 11 1
LP72 (NK clone) 11 1
C11 (NK clone) 11 1
29 (TCR a/b1 clone) 22 2
201 (TCR a/b1 clone) 22 2
13 (TCR a/b1 clone) 22 2
6 (TCR a/b1 clone) 22 2
33 (TCR a/b1 clone) 22 2
R3.2 (TCR a/b1 clone) 22 1
X50B (TCR g/d1 clone) 22 1
X50F (TCR g/d1 clone) 22 1
M50F (TCR g/d1 clone) 22 2
DG16 (TCR g/d1 clone) 22 2
DG29 (TCR g/d1 clone) 22 2
17.12 (TCR g/d1 clone) 11 1
17.31 (TCR g/d1 clone) 11 1
PBL 22 1
PHA blasts 22 1
Total thymus 22 1
Monocytes 22 1
NK3.3 (NK cell line) 22 2
NKL (NK cell line) 22 1
Jurkat (T cell line) 22 2
HSB-2 (T cell line) 22 2
CEM-B (T cell line) 22 2
MOLT-4 (T cell line) 22 2
PEER (T cell line) 22 2
LCL721.221 (B cell line) 22 2
U937 (histiocytic lymphoma) 22 1
HL60 (promyelocytic leukemia) 22 2
THP-1 (monocytic cell line) 22 1
Eo/A3 (Eosinophilic cell line) 22 1793 Cantoni et al.
TCR-a/b1 T cell clones were not stained by anti-NKp44
mAb and did not express the NKp44 transcript. The
DAP12 transcript was only expressed in one of the clones
analyzed; notably, this clone (R3.2) expressed the p50.2
activating receptor, known to associate with KARAP/
DAP12 molecules (16). Among TCR-g/d1 T cell clones,
most did not express surface NKp44 molecules. However,
two of them expressed DAP12 transcripts. Two TCR-g/d1
T cell clones (17.12 and 17.31), isolated from a single donor,
displayed low levels of surface NKp44 and expressed both
NKp44 and DAP12 transcripts. In both clones, the NKp44
receptor was functional, as revealed by redirected killing as-
says in the presence of anti-NKp44 mAbs (not shown). We
also analyzed several human cell lines of different histotype.
All these lines lacked surface expression of NKp44 and did
not display NKp44 transcripts; on the other hand, the
DAP12 transcript was also expressed in cells of nonlymphoid
origin. Unlike normal activated NK cells, the two NK cell
lines analyzed (NK3.3 and NKL) displayed neither surface
NKp44 molecules nor NKp44 transcripts.
Conservation Across Species and Chromosomal Localization of
the NKp44 Gene. Southern blot analysis of the NKp44
gene was performed on genomic DNA extracted from hu-
man, monkey, and mouse cells and digested with three dif-
ferent restriction enzymes (Fig. 5). Hybridization per-
formed with the NKp44 ORF probe under low stringency
conditions revealed a relatively simple hybridization pattern
for the NKp44 gene. Interestingly, cross-species hybridiza-
tion could be observed with both monkey and mouse ge-
nomic DNA. These data suggest that the NKp44 ORF
probe hybridizes with a single or relatively few human
genes and that the NKp44 gene may be conserved between
humans and rodents.
Chromosomal localization of the NKp44-encoding gene
was determined by two different approaches. First, we per-
formed Southern blot analysis, using genomic DNA de-
rived from a panel of polychromosomal human–hamster
cell hybrids. Hybridization with the NKp44 ORF cDNA
probe showed segregation of the NKp44 gene on human
chromosome 6. The same conclusion was achieved by
PCR analysis of a panel of genomic DNA extracted from
monochromosomal human–hamster cell hybrids by using
NKp44 specific primers (not shown). Taken together,
these results indicate that the NKp44 gene is localized on
human chromosome 6.
Discussion
The present study reports the molecular cloning of
NKp44, a NK-specific triggering receptor involved in
non-MHC–restricted natural cytotoxicity (3). Different
from NKp46 (2, 7), which is expressed by all resting and
activated NK cells, NKp44 is selectively expressed by acti-
vated human NK cells. In this context, it is well known
that culture in IL-2 greatly enhances the NK-mediated
anti-tumor cytotoxicity both in vitro (4) and in vivo (5, 6).
It is conceivable that the increased cytolytic activity medi-
ated by activated NK cells may be consequent, at least in
part, to the de novo expression of triggering receptors.
NKp44 may well represent one of these receptors since it is
involved in triggering of activated NK cells in the process
of tumor cell lysis (3).
Molecular cloning revealed that NKp44 is a type I gly-
coprotein belonging to the Ig-SF, which does not display
any major amino acid sequence homology with known
proteins. NKp44 is characterized by an extracellular region
containing an Ig-like domain of the V type. The trans-
membrane portion contains the charged amino acid lysine,
possibly involved in the association with KARAP/DAP12
molecules. Indeed, biochemical data confirmed that NKp44
associates with KARAP/DAP12 molecules (3). Moreover,
molecular cloning of NKp44 demonstrated that the associ-
ation with KARAP/DAP12 molecules is required for the
surface expression of NKp44.
Interestingly, the cytoplasmic tail of NKp44 contains a
classical ITIM (21). In this context, it is of note that, under
the experimental conditions resulting in a strong tyrosine
phosphorylation of the KARAP/DAP12 molecules associ-
ated to the NKp44 receptor (3), no tyrosine phosphoryla-
tion of the NKp44 molecule itself could be detected.
Moreover, under the same experimental conditions, no ev-
idence has been obtained so far that NKp44 may associate
with phosphatases such as SHP-1, SHP-2, or SHIP, which
have been reported to associate with ITIM-bearing recep-
tors (21). The functional role of this ITIM is presently un-
der investigation.
Remarkably, unlike most of the genes encoding Ig-SF
receptors involved in the regulation of NK cell–mediated
cytolytic activity (including KIR [1], KAR [1], NKp46 [7],
and ILT/LIR [26, 27]), which are on human chromosome
19, the NKp44 gene is on chromosome 6. Southern blot
Figure 5. Southern blot analysis of NKp44 gene. Genomic DNA (10
mg/lane) extracted from human, monkey, and mouse cells was digested
with the indicated restriction enzymes and hybridized with the NKp44
ORF probe. Molecular weight markers (23,130; 9,416; 6,557; 4,361;
2,322; 2,027; 1,353; and 1,078 bp [top to bottom]) are shown on the left.794 Molecular Cloning of the NKp44 Receptor
analysis of human genomic DNA revealed a restriction en-
zyme digestion pattern that is compatible with the exist-
ence of a single NKp44 gene. Moreover, the NKp44 gene
appears to be conserved across species since the human
NKp44 ORF cDNA probe cross-hybridized with genomic
DNA from monkey and mouse. It will be of interest to an-
alyze whether the murine counterpart of NKp44 exists and
whether its expression is restricted to NK cells and to a
subset of TCR-g/d1 T lymphocytes as it occurs in hu-
mans.
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